-
Notifications
You must be signed in to change notification settings - Fork 0
/
shared_genes_snps_snippets.tsv
We can't make this file beautiful and searchable because it's too large.
17618 lines (17618 loc) · 708 KB
/
shared_genes_snps_snippets.tsv
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
19
20
21
22
23
24
25
26
27
28
29
30
31
32
33
34
35
36
37
38
39
40
41
42
43
44
45
46
47
48
49
50
51
52
53
54
55
56
57
58
59
60
61
62
63
64
65
66
67
68
69
70
71
72
73
74
75
76
77
78
79
80
81
82
83
84
85
86
87
88
89
90
91
92
93
94
95
96
97
98
99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
591
592
593
594
595
596
597
598
599
600
601
602
603
604
605
606
607
608
609
610
611
612
613
614
615
616
617
618
619
620
621
622
623
624
625
626
627
628
629
630
631
632
633
634
635
636
637
638
639
640
641
642
643
644
645
646
647
648
649
650
651
652
653
654
655
656
657
658
659
660
661
662
663
664
665
666
667
668
669
670
671
672
673
674
675
676
677
678
679
680
681
682
683
684
685
686
687
688
689
690
691
692
693
694
695
696
697
698
699
700
701
702
703
704
705
706
707
708
709
710
711
712
713
714
715
716
717
718
719
720
721
722
723
724
725
726
727
728
729
730
731
732
733
734
735
736
737
738
739
740
741
742
743
744
745
746
747
748
749
750
751
752
753
754
755
756
757
758
759
760
761
762
763
764
765
766
767
768
769
770
771
772
773
774
775
776
777
778
779
780
781
782
783
784
785
786
787
788
789
790
791
792
793
794
795
796
797
798
799
800
801
802
803
804
805
806
807
808
809
810
811
812
813
814
815
816
817
818
819
820
821
822
823
824
825
826
827
828
829
830
831
832
833
834
835
836
837
838
839
840
841
842
843
844
845
846
847
848
849
850
851
852
853
854
855
856
857
858
859
860
861
862
863
864
865
866
867
868
869
870
871
872
873
874
875
876
877
878
879
880
881
882
883
884
885
886
887
888
889
890
891
892
893
894
895
896
897
898
899
900
901
902
903
904
905
906
907
908
909
910
911
912
913
914
915
916
917
918
919
920
921
922
923
924
925
926
927
928
929
930
931
932
933
934
935
936
937
938
939
940
941
942
943
944
945
946
947
948
949
950
951
952
953
954
955
956
957
958
959
960
961
962
963
964
965
966
967
968
969
970
971
972
973
974
975
976
977
978
979
980
981
982
983
984
985
986
987
988
989
990
991
992
993
994
995
996
997
998
999
1000
gene snp snippet
ABCA1 Rs2230808 Alzheimer's disease
ABCA1 Rs2230808 polymorphisms and Alzheimer's disease.
ABCA1 Rs2230808 schizophrenia and related brain changes.
ABCA1 Rs2230808 polymorphism
ABCA1 Rs2230808 dementia
ABCA1 Rs2230808 polymorphisms.
ABCA1 Rs2230808 polymorphisms
ABCA1 Rs2230808 Alzheimer's disease
ABCA1 Rs2230808 cholesterol levels
ABCA1 Rs2230808 brain changes
ABCA1 Rs2230808 schizophrenia
ABCA1 Rs2230808 HDL cholesterol levels
ABCA1 Rs2230808 ischaemic stroke
ABCA1 Rs2230808 cerebrospinal fluid
ABCA1 Rs2230808 cholesterol
ABCA1 Rs4149268 good cholesterol
ABCA1 Rs4149268 increase in HDL cholesterol
ABCA1 Rs4149268 0.82mg/dl increase in HDL cholesterol
ABCA1 Rs2297404 rs2020927
ABCA1 Rs2297404 rs2230808
ABCA1 Rs2297404 rs2297404,
ABCA1 Rs2297404 ver-represented in the healthy controls
ABCA1 Rs2297404 haplotype1
ABCA1 Rs2230808 ABCA1 polymorphisms
ABCA1 Rs2297404 Alzheimer's disease group
ABCA1 Rs2297404 haplotype1
ABCA1 Rs2297404 rs2020927
ABCA1 Rs2297404 rs2297404
ABCA1 Rs2297404 Alzheimer's disease
ABCA1 Rs2297404 TGG
ABCA1 Rs2230808 CSF cholesterol levels
ABCA1 Rs2020927 while haplotype1 (TGG) was over-represented in the healthy controls
ABCA1 Rs2020927 rs2297404, rs2230808, and rs2020927 haplotype (CAC) was more prevalent in the Alzheimer's disease group
ABCA1 Rs2020927 rosiglitazone
ABCA1 Rs2020927 patients with Type 2 diabetes
ABCA1 Rs2020927 Alzheimer's disease
ABCA1 Rs2020927 Type 2 diabetes treated with rosiglitazone.
ABCA1 Rs2020927 atherogenic dyslipidaemia
ABCA1 Rs2020927 Alzheimer's disease group
ABCA1 Rs2020927 healthy controls
ABCA1 Rs2020927 haplotype1
ABCA1 Rs2020927 haplotype
ABCA1 Rs2020927 Type 2 diabetes
ABCA1 Rs1883025 Mexican dyslipidemic
ABCA1 Rs1883025 risk for carotid artery disease
ABCA1 Rs1800977 therothrombotic cerebral infarction
ABCA1 Rs1800977 polymorphism
ABCA1 Rs2066714 chronic kidney disease
ABCA1 Rs2230808 schizophrenia
ABCA1 Rs2066714 preterm delivery
ABCA1 Rs2230806 hyperlipidemic
ABCA1 Rs2230806 postprandial lipoproteins
ABCA1 Rs2230806 ischaemic stroke
ABCA1 Rs2230806 Alzheimer's disease
ABCA1 Rs2230806 coronary artery disease
ABCA1 Rs2230806 HDL-C
ABCA1 Rs2230806 coronary artery disease
ABCA1 Rs2066714 Japanese individuals
ABCA1 Rs2230806 dementia
ABCA12 Rs28940271 congenital Lamellar ichthyosis
ABCA12 Rs28940271 skin condition
ABCA12 Rs28940271 Lamellar ichthyosis
ABCA12 Rs28940271 recessive SNP
ABCA12 Rs28940271 congenital Lamellar ichthyosis, type 2, also called ichthyosis-4A, a significant skin condition.
ABCA12 Rs28940568 recessive SNP
ABCA12 Rs28940568 skin condition
ABCA12 Rs28940568 Lamellar ichthyosis
ABCA12 Rs28940568 congenital Lamellar ichthyosis, type 2, also called ichthyosis-4A, a significant skin condition.
ABCA12 Rs28940270 congenital Lamellar ichthyosis, type 2, also called ichthyosis-4A, a significant skin condition.
ABCA12 Rs28940568 congenital Lamellar ichthyosis
ABCA12 Rs28940270 skin condition
ABCA12 Rs28940270 recessive SNP
ABCA12 Rs28940268 recessive SNP
ABCA12 Rs28940268 congenital Lamellar ichthyosis
ABCA12 Rs28940268 skin condition
ABCA12 Rs28940268 Lamellar ichthyosis
ABCA12 Rs28940268 congenital Lamellar ichthyosis, type 2, also called ichthyosis-4A, a significant skin condition.
ABCA12 Rs28940269 congenital Lamellar ichthyosis
ABCA12 Rs28940270 Lamellar ichthyosis
ABCA12 Rs28940269 Lamellar ichthyosis
ABCA12 Rs28940269 recessive SNP
ABCA12 Rs28940269 skin condition
ABCA12 Rs28940269 congenital Lamellar ichthyosis, type 2, also called ichthyosis-4A, a significant skin condition.
ABCA12 Rs28940270 congenital Lamellar ichthyosis
ABCA7 Rs3764650 disease
ABCA7 Rs78117248 rs78117248(G) allele
ABCA7 Rs78117248 Alzheimer's disease
ABCA7 Rs78117248 ABCA7 gene
ABCA7 Rs7408475 Alzheimer's disease polygenic hazard score
ABCA7 Rs72973581 Alzheimer's disease cases identified
ABCA7 Rs4147929 late onset Alzheimer's disease
ABCA7 Rs3764650 Alzheimer's
ABCA7 Rs3764650 Alzheimer's disease
ABCA7 Rs200538373 loss-of-function ABCA7 mutations
ABCA7 Rs200538373 is one of several loss-of-function ABCA7 mutations associated with Alzheimer's disease initially in Icelanders
ABCA7 Rs200538373 late-onset Alzheimer's disease
ABCA7 Rs200538373 Alzheimer's disease
ABCA7 Rs200538373 late-onset Alzheimer's disease
ABCA7 Rs113809142 Carriers of one rare rs113809142(G) allele are at roughly more than twice the risk for developing late-onset Alzheimer's disease compared to people having the most common genotype (T;T);
ABCA7 Rs113809142 rs113809142, also known as c.4416+2T>G, is one of several loss-of-function ABCA7 mutations associated with Alzheimer's disease
ABCA7 Rs200538373 developing late-onset Alzheimer's disease compared to people having the most common genotype
ABCB1 Rs1128503 allogeneic hematopoietic stem cell transplantation
ABCB1 Rs1128503 ciclosporin exposure
ABCB1 Rs1128503 Pazopanib-induced hyperbilirubinemia
ABCB1 Rs1128503 Gilbert's syndrome
ABCB1 Rs1128503 nephrotic syndrome
ABCB1 Rs1128503 cancer
ABCB1 Rs1128503 myeloid leukemia
ABCB1 Rs1045642 Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics
ABCB1 Rs1128503 major depressive disorder
ABCB1 Rs12720067 depression
ABCB1 Rs12720067 depression
ABCB1 Rs12720067 German inpatients
ABCB1 Rs1128503 functional polymorphism (C3435T) of the gene encoding P-glycoprotein
ABCB1 Rs1128503 antidepressant response
ABCB1 Rs1045642 Part II
ABCB1 Rs1128503 liver transplant
ABCB1 Rs1045642 Pazopanib-induced hyperbilirubinemia is associated with Gilbert's syndrome UGT1A1 polymorphism.
ABCB1 Rs1045642 Cytochrome P450 genetic polymorphisms influence the serum concentration of calcineurin inhibitors in allogeneic hematopoietic SCT recipients
ABCB1 Rs1045642 The effects of CYP3A4, CYP3A5, ABCB1, ABCC2, ABCG2 and SLCO1B3 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of docetaxel in nasopharyngeal carcinoma patients.
ABCB1 Rs1045642 Common variants in ABCB1, ABCC2 and ABCG2 genes and clinical outcomes among women with advanced stage ovarian cancer treated with platinum and taxane-based chemotherapy: a Gynecologic Oncology Group study.
ABCB1 Rs1045642 olymorphism and cancer risk
ABCB1 Rs1128503 opiate dependence
ABCB1 Rs1128503 requiring the 'higher' methadone dose
ABCB1 Rs1128503 dementia
ABCB1 Rs1128503 age-matched non-demented control patients
ABCB1 Rs1128503 childhood acute lymphoblastic leukemia
ABCB1 Rs1128503 addictive diseases
ABCB1 Rs1128503 drug-refractory epilepsy
ABCB1 Rs1128503 ABCB1 polymorphisms
ABCB1 Rs1128503 major depression
ABCB1 Rs2032582 lung cancer
ABCB1 Rs2235040 influence the intracerebral concentrations of certain drugs
ABCB1 Rs2032582 Crohn's disease
ABCB1 Rs2235067 depression
ABCB1 Rs3842 lung cancer
ABCB1 Rs3842 women
ABCB1 Rs3842 cancer
ABCB1 Rs7787082 antidepressant effect
ABCB1 Rs7787082 depression
ABCB1 Rs7787082 eight
ABCB1 Rs7787082 n clinic, even the lower concentrations of drugs may achieve sufficient antidepressant effect,
ABCB1 Rs7787082 The list of the 9 SNPs is shown below.When treated for depression with citalopram, paroxetine, amitriptyline, or venlafaxine
ABCB1 Rs7787082 antidepressants
ABCB1 Rs7787082 German
ABCB1 Rs7787082 rs7787082 is a SNP in the ABCB1 gene (also known as the MDR1 gene), which encodes a protein that transports certain molecules across the blood-brain barrier
ABCB1 Rs2032582 squamous cell carcinoma
ABCB1 Rs2235067 depression
ABCB1 Rs2235040 their efficacy or potential for adverse side effects
ABCB1 Rs2032582 association with Crohn's disease.
ABCB1 Rs2032582 type of lung cancer called squamous cell carcinoma
ABCB1 Rs2032582 heavy smokers
ABCB1 Rs2032582 Crohn's disease.
ABCB1 Rs2235040 clinical effect in depression
ABCB1 Rs2235035 colorectal cancers
ABCB1 Rs2235035 Crohn disease
ABCB1 Rs2235035 ulcerative colitis
ABCB1 Rs2235035 refractory Crohn disease
ABCB1 Rs2032582 homozygotes,
ABCB1 Rs1045642 Polymorphisms in the xenobiotic transporter Multidrug Resistance 1 (MDR1) and interaction with meat intake in relation to risk of colorectal cancer in a Danish prospective case-cohort study. Effect of CYP3A and ABCB1 single nucleotide polymorphisms on the pharmacokinetics and pharmacodynamics of calcineurin inhibitors: Part I.
ABCB1 Rs1045642 major depressive disorder
ABCB1 Rs1045642 Third National Health and Nutrition Examination Survey, 1991-1994.
ABCB1 Rs1045642 carcinoma
ABCB1 Rs1045642 epilepsy
ABCB1 Rs1045642 dementia
ABCB1 Rs1045642 colorectal cancer
ABCB1 Rs1045642 acute lymphoblastic leukemia
ABCB1 Rs1045642 sporadic colorectal cancer
ABCB1 Rs1045642 sophageal cancer.
ABCB1 Rs1045642 B-precursor acute lymphoblastic leukemia
ABCB1 Rs1045642 osteonecrosis
ABCB1 Rs1045642 cancer
ABCB1 Rs1045642 lung cancer
ABCB1 Rs1045642 rheumatoid arthritis
ABCB1 Rs1045642 minimal residual disease
ABCB1 Rs1045642 osteonecrosis
ABCB1 Rs1045642 Genetic determinants of target and novelty-related event-related potentials in the auditory oddball response
ABCB1 Rs10248420 depression
ABCB1 Rs10248420 depressio
ABCB1 Rs10248420 colonic disease
ABCB1 Rs10248420 depression
ABCB1 Rs10248420 colonic disease
ABCB1 Rs1045642 Polymorphisms in genes that regulate cyclosporine metabolism affect cyclosporine blood levels and clinical outcomes in patients who receive allogeneic hematopoietic stem cell transplantation.
ABCB1 Rs1045642 esophageal cancer.
ABCB1 Rs1045642 Pharmacogenetics of antidepressant response. Correlation between genetic polymorphisms
ABCB1 Rs1045642 "rs1045642, also known as C3435T, is a SNP located in the ABCB1 gene. It is often studied in conjunction with rs2032582. C3435T has been mentioned by: A ""Silent"" Polymorphism in the MDR1 Gene Changes Substrate Specificity (for example, to verapamil) (R)-lansoprazole (Prevacid) concentrations are significantly increased in CYP2C19 extensive metabolizers with ABCB1 C3435T C allele. In a Korean population, plasma concentrations of fexofenadine (Allegra) were 17% lower in 2677AA/3435CC subjects and 47% higher in the 2677TT/3435TT subjects compared to 2677GG/3435CC subjects. In contrast, in this study no association was observed between the C3435T polymorphism and fexofenadine plasma or urine concentrations in a German Caucasian population. A meta-analysis including 9 case-control studies (totaling ~2,500 patients) found no association between rs1045642 and epilepsy riskA study of 98 methadone-maintaining patients concluded that the higher (>150 mg/day) and lower (< or =150 mg/day) methadone dose groups differed significantly in their rs1128503 status (experiment-wise p = 0.0325). Furthermore, individuals with the 3-locus genotype pattern (T;T)-(T;T)-(T;T) for SNPs rs1045642, rs2032582 and rs1128503, respectively, had an approximately 5-fold chance of requiring the 'higher' methadone dose, while individuals heterozygous for these three SNPs have an approximately 3-fold chance of stabilizing at the 'lower' methadone dose (point-wise p-value = 0.026). Identifying candidate causal variants responsible for altered activity of the ABCB1 multidrug resistance gene. Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin. ABCB1 genotypes and haplotypes in patients with dementia and age-matched non-demented control patients. Association of MDR1 genotypes with susceptibility to colorectal cancer in older non-smokers. Genetic studies of a cluster of acute lymphoblastic leukemia cases in Churchill County, Nevada. MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia. No association between MDR1 (ABCB1) 2677G>T and 3435C>T polymorphism and sporadic colorectal cancer among Bulgarian patients. ABCB1 (MDR1) gene polymorphisms are associated with the clinical response to paroxetine in patients with major depressive disorder. Pharmacogenetics of minimal residual disease response in children with B-precursor acute lymphoblastic leukemia: a report from the Children's Oncology Group. Multiplexed genotyping of ABC transporter polymorphisms with the Bioplex suspension array. A PAI-1 (SERPINE1) polymorphism predicts osteonecrosis in children with acute lymphoblastic leukemia: a report from the Children's Oncology Group. Association of ABCB1 genetic variants with renal function in Africans and in Caucasians. Genotyping panel for assessing response to cancer chemotherapy. Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues. Bidirectional translational research: Progress in understanding addictive diseases. The pharmacokinetics and pharmacogenomics of efavirenz and lopinavir/ritonavir in HIV-infected persons requiring hemodialysis. No association of ABCB1 polymorphisms with drug-refractory epilepsy in a north Indian population. Germline genetic variations in drug action pathways predict clinical outcomes in advanced lung cancer treated with platinum-based chemotherapy. Prevalence in the United States of selected candidate gene variants: Third National Health and Nutrition Examination Survey, 1991-1994. Opiate and cocaine addiction: from bench to clinic and back to the bench. Investigation of candidate polymorphisms and disease activity in rheumatoid arthritis patients on methotrexate. Steroid biosynthesis and renal excretion in human essential hypertension: association with blood pressure and endogenous ouabain. Genetic determinants of target and novelty-related event-related potentials in the auditory oddball response. ABCB1 (MDR1) rs1045642 is associated with increased overall survival in plasma cell myeloma. No significant effect of ABCB1 haplotypes on the pharmacok"
ABCB1 Rs1045642 arthritis
ABCB1 Rs1045642 dementia
ABCB1 Rs1045642 colorectal cancer
ABCB1 Rs1045642 hypertension
ABCB1 Rs1045642 plasma cell myeloma
ABCB1 Rs1045642 Gilbert's syndrome
ABCB1 Rs1045642 nephrotic syndrome
ABCB1 Rs1045642 psychiatric diseases
ABCB1 Rs1045642 rs1045642,
ABCB1 Rs1045642 is a SNP located in the ABCB1 gene
ABCB1 Rs1045642 " A ""Silent"" Polymorphism in the MDR1 Gene"
ABCB1 Rs1045642 esophageal cancer
ABCB1 Rs1045642 A meta-analysis including 9 case-control studie
ABCB1 Rs1045642 SNPs have an approximately 3-fold chance of stabilizing at the 'lower' methadone dose
ABCB1 Rs1045642 Genetic predictors of the maximum doses patients receive during clinical use of the anti-epileptic drugs carbamazepine and phenytoin.
ABCB1 Rs1045642 Association of MDR1 genotypes with susceptibility to colorectal cancer in older non-smokers.
ABCB1 Rs1045642 MDR1 gene variants, indoor insecticide exposure, and the risk of childhood acute lymphoblastic leukemia. No association between MDR1
ABCB1 Rs1045642 a report from the Children's Oncology Group
ABCB1 Rs1045642 response to cancer chemotherapy. Polymorphisms affecting gene transcription and mRNA processing in pharmacogenetic candidate genes: detection through allelic expression imbalance in human target tissues. Bidirectional translational research:
ABCB1 Rs1045642 found no association between rs1045642 and epilepsy risk
ABCB1 Rs1045642 depressive disorder
ABCB1 Rs1045642 were 17% lower in 2677AA/3435CC subjects and 47% higher
ABCB1 Rs1045642 lymphoblastic leukemia
ABCB1 Rs1045642 chronic-phase chronic myeloid leukemia
ABCB1 Rs1045642 schizophrenia
ABCB1 Rs1045642 nasopharyngeal carcinoma
ABCB1 Rs1045642 calcineurin inhibitor nephrotoxicity
ABCB1 Rs1045642 chronic myeloid leukemia
ABCB1 Rs1045642 hepatitis A
ABCB1 Rs1045642 major depressive disorder
ABCB1 Rs1045642 cancer risk
ABCB4 Rs45575636 cholestasis of pregnancy
ABCB4 Rs58238559 atrial fibrillation/flutter
ABCC2 Rs717620 nonalcoholic fatty liver disease
ABCC2 Rs717620 intrahepatic cholestasis
ABCC2 Rs3740065 invasive breast cancer
ABCC2 Rs2273697 neurological adverse drug reactions
ABCC2 Rs2273697 epilepsy
ABCC2 Rs2273697 reduced carbamazepine transport across the cell membrane.
ABCC6 Rs63749823 pseudoxanthoma elasticum
ABCC6 Rs63749823 ABCC6 mutations
ABCC6 Rs63749796 mutations
ABCC6 Rs63749796 Novel
ABCC6 Rs212077 genes for familial combined hyperlipidemia.
ABCC6 Rs63749796 pseudoxanthoma elasticum
ABCC8 Rs151344624 focal CHI
ABCC8 Rs151344624 is reported to be 1 in 52, giving an estimated frequency
ABCC8 Rs151344624 somatic loss
ABCC8 Rs151344624 pregnancy
ABCC8 Rs151344624 mutation
ABCC8 Rs151344623 focal form of the disease
ABCC8 Rs151344623 somatic loss
ABCC8 Rs151344623 pregnancy
ABCC8 Rs151344623 offspring
ABCC8 Rs151344623 risk
ABCC8 Rs151344623 focal
ABCC8 Rs151344623 1 in 10,816 in this population
ABCC8 Rs151344624 This variant is considered a founder mutation
ABCC8 Rs151344623 mutation
ABCC8 Rs151344623 estimated frequency
ABCC8 I5012556 Familial Hyperinsulinism
ABCC8 I5012558 Familial Hyperinsulinism
ABCC8 Rs1048095 permanent neonatal diabetes mellitus (PNDM)
ABCC8 Rs1048095 permanent neonatal diabetes mellitus
ABCC8 I5008233 Familial Hyperinsulinism
ABCC8 Rs151344623 compound heterozygosity
ABCC8 Rs151344623 somatic loss of heterozygosity
ABCC8 Rs151344623 variant
ABCC8 Rs151344623 homozygosity
ABCC9 Rs4148649 associated with postural changes in blood pressure.
ABCC9 Rs4148649 postural changes in
ABCC9 Rs4148649 postural changes in blood pressure
ABCC9 Rs4148649 blood pressure
ABCC9 Rs4148649 Genes controlling postural changes
ABCC9 Rs4148649 ATP-sensitive potassium channel genes
ABCC9 Rs4148649 haplotype
ABCC9 Rs4762865 blood pressure
ABCC9 Rs4762865 postural changes in
ABCC9 Rs4762865 postural changes in blood pressure
ABCC9 Rs4762865 Genes controlling postural changes
ABCC9 Rs4762865 ATP-sensitive potassium channel genes
ABCC9 Rs4762865 haplotype
ABCC9 Rs4762865 associated with postural changes in blood pressure.
ABCC9 Rs2955503 postural changes
ABCC9 Rs11046232 blood pressure
ABCC9 Rs11046232 postural changes in
ABCC9 Rs11046232 postural changes in blood pressure
ABCC9 Rs11046232 Genes controlling postural changes
ABCC9 Rs11046232 ATP-sensitive potassium channel genes
ABCC9 Rs11046232 haplotype
ABCC9 Rs11046232 associated with postural changes in blood pressure.
ABCC9 Rs2900492 postural changes in blood pressure
ABCC9 Rs2900492 postural changes in blood pressure.
ABCC9 Rs2955503 haplotype
ABCC9 Rs2955503 blood pressure
ABCC9 Rs2955503 ATP-sensitive potassium channel genes
ABCD1 Rs398123109 adrenoleukodystrophy (ALD)
ABCD1 Rs398123109 pathogenic for adrenoleukodystrophy (ALD)
ABCD1 Rs398123109 adrenoleukodystrophy
ABCD1 Rs398123104 pathogenic for adrenoleukodystrophy
ABCD1 Rs1131691743 adrenoleukodystrophy
ABCD1 Rs1057518721 deafness, dystonia, and cerebral hypomyelination
ABCD1 Rs398123104 pathogenic for adrenoleukodystrophy (ALD)
ABCG2 Rs2231142 4,000 African-American individuals who took part in the study of Atherosclerosis Risk in Communities
ABCG2 Rs3114018 gout
ABCG2 Rs3114018 Han Chinese
ABCG2 Rs3114018 haplotype blocks
ABCG2 Rs2231142 lung cancer
ABCG2 Rs2231142 Atherosclerosis
ABCG2 Rs2231142 "rs2231142, also known as Q141K and C421A, is a SNP in the ABCG2 gene, indicating a missense variant. ""Our data indicate that at least 10% of all gout cases in whites are attributable to this causal variant.""A is the risk allele. A large study totaling 7,699 participants in the Framingham cohort and 4,148 participants in the Rotterdam cohort was conducted, with genome-wide significant SNPs then replicated in 11,000+ Caucasian and ~4,000 African-American individuals who took part in the study of Atherosclerosi"
ABCG2 Rs2231142 Atherosclerosis Risk
ABCG2 Rs2231142 diarrhea
ABCG2 Rs2231137 ischemic stroke
ABCG2 Rs1481012 colorectal cancer
ABCG2 Rs1481012 gene-wide
ABCG2 Rs1481012 polymorphisms
ABCG2 Rs2231137 stroke
ABCG2 Rs2231142 heterozygotes
ABCG2 Rs2231137 allele homozygotes
ABCG2 Rs2231137 white
ABCG2 Rs2231137 black
ABCG8 Rs6756629 increased HDL cholesterol levels
ABCG8 Rs6756629 gallstone disease
ABCG8 Rs6756629 decreased triglyceride levels
ABCG8 Rs41360247 increases susceptibility to Gallstone disease
ABCG8 Rs6756629 decreased LDL levels
ABCG8 Rs11887534 Up to 10% of the population attributable risk for gallstones may be accounted for by this SNP.
ABCG8 Rs11887534 rs11887534, a SNP in the hepatic cholesterol transporter ABCG8 gene, has been implicated in gallstone disease, a process known formally as cholelithiasis.
ABCG8 Rs11887534 p=1.4x10-14),
ABCG8 Rs41360247 Gallstone disease
ABO Rs8176719 blood group type O
ABO Rs8176719 blood group type A or type B
ABO Rs8176719 blood group type O status
ABO Rs8176694 SNP
ABO Rs8176694 genosets
ABO Rs8176694 ABO blood group
ABO Rs657152 men and women
ABO Rs657152 pancreatic cancer
ABO Rs657152 thyroid
ABO Rs657152 ABO blood group
ABO Rs657152 women
ABO Rs657152 ABO histo-blood
ABO Rs7853989 ABO Blood Type
ABO Rs8176719 blood type A
ABO Rs8176749 SNP
ABO Rs8176719 blood type A, B, or AB
ABO Rs574347 SNP
ABO Rs8176750 A2 type allele
ABO Rs8176750 A1 type
ABO Rs8176750 use of genosets.
ABO Rs8176750 ABO gene,
ABO Rs8176749 determing ABO blood group
ABO Rs8176749 ABO gene
ABO Rs8176747 ABO Blood Type
ABO Rs8176746 A/C
ABO Rs8176746 G/T
ABO Rs8176743 ABO Blood Type
ABO Rs8176741 blood group type
ABO Rs8176740 Influences ABO blood group
ABO Rs8176719 blood group types A, B, and AB
ABO Rs8176719 type O
ABO Rs8176719 blood type B
ABO Rs574347 genosets
ABO Rs507666 sICAM-1 concentrations
ABO Rs56392308 A2 ABO blood
ABO Rs2073828 genosets
ABO Rs574347 ABO blood group
ABO Rs2073824 determing ABO blood group
ABO Rs2073824 ABO gene
ABO Rs2073824 SNP
ABO Rs1053878 ABO Blood Type
ABO Rs1053878 phenotype
ABO Rs1053878 ABO blood group
ABO Rs1053878 cis-AB phenotype
ABO Rs1053878 blood group
ABO Rs1008708453 is reported to be completely correlated to a subtype of O type alleles known as the O2 group
ABO I4000505 Influences ABO blood group
ABO I4000504 Influences ABO blood group
ABO Rs2073828 SNP
ABO Rs41302905 may influence ABO blood group see gs129ABO Blood Type
ABO Rs2073828 ABO blood group
ABO Rs41302905 Blood Type
ABO Rs512770 SNP
ABO Rs512770 genosets
ABO Rs512770 ABO blood group
ABO Rs507666 regulatory role of histo-blood group antigens in inflammatory adhesion processes.
ABO Rs41302905 ABO blood group
ABO Rs507666 ABO blood group
ABO Rs507666 blood
ABO Rs507666 histo
ABO Rs505922 pancreatic cancer
ABO Rs500498 SNP
ABO Rs500498 genosets
ABO Rs500498 ABO blood group
ABO Rs41302905 may influence ABO blood group
ABO Rs507666 histo-blood
ACADM Rs200724875 Arg206His
ACADM Rs121434280 temperature-sensitive mutation
ACADM I5003117 Medium-Chain
ACADM I5003116 Dehydrogenase Deficiency
ACADM I5003117 Dehydrogenase Deficiency
ACADVL Rs113994167 mutations associated with VLCAD deficiency
ACADVL Rs140629318 pathogenic very long chain acyl-CoA dehydrogenase deficiency mutations
ACAT1 Rs779565865 pathogenic variant
ACAT1 Rs3741049 fatty
ACAT1 Rs3741049 acid
ACAT1 Rs3741049 metabolites
ACAT1 Rs3741049 clostridia
ACAT1 Rs3741049 ketothiolase
ACAT1 Rs3741049 Methylation
ACAT1 Rs3741049 elevated fatty acid metabolites
ACAT1 Rs3741049 3-ketothiolase deficiency
ACAT1 Rs3741049 ketone body metabolism
ACAT1 Rs3741049 metabolism
ACE Rs4311 diabetic nephropathy.
ACE Rs4311 diabetic nephropathy 4x.
ACE Rs4311 risk allele T
ACE Rs4311 risk of diabetic nephropathy 4x
ACE Rs4311 increased risk of diabetic nephropathy
ACE Rs4340 "Alleles containing the insertion are called ""I"" alleles, and ""D"" alleles lack the repetitive elemen"
ACE Rs4340 insertion/deletion of an Alu repetitive element in an intron of the ACE gene
ACE Rs4340 early-onset psoriasis
ACE Rs4340 erectile dysfunction.
ACE Rs4343 diabetic nephropathy
ACE Rs4353 late-onset Alzheimer disease
ACE Rs4353 Confronting complexity in late-onset Alzheimer disease: application of two-stage analysis approach addressing heterogeneity and epistasis.
ACE Rs4353 An association analysis of Alzheimer disease candidate genes detects an ancestral risk haplotype clade in ACE and putative multilocus association between ACE, A2M, and LRRTM3.
ACE Rs4359 anti-hypertensive drug ramipril
ACE Rs4359 SNP
ACE Rs4311 diabetic nephropath
ACE Rs4340 "Alleles containing the insertion are called ""I"" alleles"
ACE Rs4293 Alzheimer's disease
ACE Rs12449782 G allele is associated with a slightly increased risk
ACE Rs4293 SNP
ACE Rs12449782 diabetic nephropathy
ACE Rs13447447 early-onset psoriasis
ACE Rs13447447 SNPs
ACE Rs13447447 SNP
ACE Rs13447447 erectile dysfunction
ACE Rs1799752 "ad, it is an insertion/deletion of an Alu repetitive element in an intron of the ACE gene. Alleles containing the insertion are called ""I"" alleles, and ""D"" alleles lack the repetitive element. The other dbSNP entries all tagging this same single insertion/deletion SNP are: rs4340 rs13447447 rs4646994There are numerous association studies reported for these SNPs. Examples: (D/D) homozygosity is associated with more marked hypertrophy of the left ventricle and may be associated with higher risk of adverse outcomes among carriers of familial hypertrophic cardiomyopathy mutations (I;I) homozygotes respond better to Viagra than (D;I) or (D;D) individuals"
ACE Rs1799752 "rs1799752 is one of four SNPs representing perhaps the best studied ACE SNP. It is actually not a single nucleotide polymorphism at all; instead, it is an insertion/deletion of an Alu repetitive element in an intron of the ACE gene. Alleles containing the insertion are called ""I"" alleles, and ""D"" alleles lack the repetitive element. The other dbSNP entries all tagging this same single insertion/deletion SNP are: rs4340 rs13447447 rs4646994There are numerous association studies reported for these SNPs. Examples: (D/D) homozygosity is associated with more marked hypertrophy of the left ventricle and may be associated with higher risk of adverse outcomes among carriers of familial hypertrophic cardiomyopathy mutations (I;I) homozygotes respond better to Viagra than (D;I) or (D;D) individuals, in a study of 100+ Caucasian men with erectile dysfunction. (OR 3.07, CI: 1.03 - 9.13, p=0.04). (I;I) homozygotes are are higher risk for early-onset psoriasis, with an odds ratio of 1.88 (CI: 1.12-3.15, p=0.016)./ 23andMe blog snp puts women with migraines at higher risk for cardiovascular disease This is flatly contradicted by , which in a study of 4,577 women over 12 years found no association between rs1799752 and migraine or migraine aura status.According to a table published by the Alzheimer Research Forum, this SNP may be associated with susceptibility to Alzheimer's disease"
ACE Rs1799752 erectile dysfunction.
ACE Rs1799752 migraine or migraine aura status
ACE Rs1799752 Alzheimer Research Forum
ACE Rs1799752 Alzheimer's disease.
ACE Rs1799752 " single nucleotide polymorphism at all; instead, it is an insertion/deletion of an Alu repetitive element in an intron of the ACE gene. Alleles containing the insertion are called ""I"" alleles, and ""D"" alleles lack the repetitive element. The other dbSNP entries all tagging this same single insertion/deletion SNP are: rs4340 rs13447447 rs4646994There are numerous association s"
ACE Rs1799752 contradicted by , which in a study of 4,577 women over 12 years
ACE Rs4293 Alzheimer's disease.
ACE Rs1799752 familial hypertrophic cardiomyopathy mutations
ACKR1 Rs2814778 Namibian San
ACKR1 Rs2814778 African populations
ACKR1 Rs2814778 European populations and southwestern Native American populations
ACKR1 Rs2814778 white blood cell and neutrophil count
ACKR1 Rs2814778 Malaria Resistance (Duffy Antigen)
ACKR1 Rs2814778 rs2814778
ACKR1 Rs2814778 SNP
ACKR1 Rs2814778 Duffy blood group antigen
ACKR1 Rs2814778 CEPH-HGDP
ACKR1 Rs2814778 rs2814778 (G) allele
ACKR1 Rs2814778 rs2814778 (A)
ACKR1 Rs2814778 non-Ashkenazi Jewish populations
ACKR1 Rs2814778 DARC gene
ACKR1 Rs2814778 Czech gypsies
ACKR1 Rs2814778 Plasmodium vivax malaria
ACKR1 Rs2814778 Europeans
ACKR1 Rs12075 blood group antigen system
ACKR1 Rs12075 p.Gly42Asp
ACKR1 Rs12075 Duffy blood group antigen system
ACKR1 Rs12075 For some frequencies of the resulting phenotypes for this variant, see the ACKR1 page.
ACKR1 Rs2814778 those with African ancestry.
ACKR1 Rs2814778 malaria
ACKR1 Rs2814778 Duffy blood group antigen
ACKR1 Rs2814778 Plasmodium vivax malaria
ACKR1 Rs2814778 Malaria
ACKR1 Rs2814778 Malaria Resistance
ACTA2 Rs1926203 lung cancer risk
ACTA2 Rs1926203 Genome-wide significant association
ACTA2 Rs1926203 lung cancer risk
ACTA2 Rs1926203 lung cancer
ACTA2 Rs121434528 ministrokes
ACTA2 Rs121434528 transient ischemic attacks
ACTA2 Rs121434528 arteries at the base of the brain are blocked
ACTA2 Rs121434528 Moyamoya,
ACTA2 Rs121434528 moyamoya-like cerebrovascular disease
ACTA2 Rs121434528 familial thoracic aortic aneurysm and dissection (TAAD)
ACTA2 Rs121434528 Strokes
ACTC1 Rs193922680 rare minor allele
ACTC1 Rs193922680 left ventricular noncompaction
ACTC1 Rs193922680 autosomal dominant
ACTC1 Rs193922680 hypertrophic cardiomyopathy (HCM)
ACTC1 Rs193922680 pathogenic/likely pathogenic
ACTC1 Rs193922680 eft ventricular noncompaction
ACTC1 Rs193922680 amilial hypertrophic cardiomyopathy
ACTG1 Rs28999111 deafness
ACTG1 Rs28999112 deafness
ACTN1 Rs117672662 allele is around 7% in many South American populations
ACTN1 Rs117672662 under 1%
ACTN3 Rs1815739 athletic status
ACTN3 Rs1815739 life course physical capability
ACTN3 Rs1815739 leg muscle power
ACTN3 Rs1815739 SNPs
ACTN3 Rs1815739 muscle performance
ACTN3 Rs1815739 endurance ability
ACTN3 Rs1815739 polymorphism
ACTN3 Rs1815739 power/sprint performance
ACTN3 Rs1815739 explosive leg muscle power
ACTN3 Rs1815739 performance phenotypes i
ACTN4 Rs121908415 Focal segmental glomerulosclerosis
ACTN4 Rs121908416 Focal segmental glomerulosclerosis
ACTN4 Rs121908417 Focal segmental glomerulosclerosis
ADA Rs121908739 adenosine deaminase deficiency
ADA Rs121908739 adenosine deaminase deficiency.
ADA Rs121908738 adenosine deaminase deficiency
ADA Rs121908738 adenosine deaminase deficiency.
ADA Rs121908735 SCID
ADA Rs121908736 adenosine deaminase deficiency.
ADA Rs121908735 ADA
ADA Rs121908736 adenosine deaminase deficiency
ADAM10 I6006818 Alzheimer's disease assocation
ADAM10 Rs145518263 Alzheimer's diseas
ADAM10 Rs145518263 Alzheimer's disease
ADAM10 I6006818 Alzheimer's disease
ADAM10 Rs61751103 Alzheimer's disease
ADAM10 I6006817 Alzheimer's disease assocation
ADAM10 I6006817 Alzheimer's disease
ADAMTS13 Rs28647808 type-2 diabetes
ADAMTS13 Rs28647808 higher renal or cardiavascular complications
ADAMTS13 Rs28647808 50% higher risk for renal complications
ADCY3 Rs541941351 reverse orientation of the gene.
ADCY3 Rs541941351 orientation & ambiguous flip
ADCY3 Rs541941351 heterozygotes
ADCY3 Rs541941351 inherited recessively
ADCY3 Rs541941351 obesity
ADCY3 Rs541941351 potentially causing obesity
ADCY3 Rs541941351 ADCY3 gene
ADCY3 Rs541941351 rare variant in the ADCY3 gene
ADCY5 Rs796065306 dyskinesia disorder.
ADCY5 Rs796065306 facial myokymia
ADCY5 Rs796065306 autosomal dominant familial dyskinesia,
ADCY5 Rs796065306 autosomal dominant familial dyskinesia
ADCY5 Rs796065306 dyskinesia disorder
ADCY5 Rs11708067 glucose and insulin responses
ADH1B Rs1229984 Alcohol dehydrogenase
ADH1B Rs6413413 Spaniards
ADH1B Rs6413413 SNP
ADH1B Rs6413413 SNP
ADH1B Rs1229984 aerodigestive tract cancer
ADH1B Rs1229984 squamous cell carcinoma of the head and neck
ADH1B Rs1229984 alcohol-induced medical diseases
ADH1B Rs1229984 coronary heart disease
ADH1B Rs1229984 diabetes
ADH1B Rs1229984 chronic liver disease
ADH1B Rs1229984 migraine attacks
ADH1B Rs1229984 migraine
ADH1B Rs1229984 fetal alcohol syndromes
ADH1B Rs1229984 cance
ADH1B Rs1229984 """upper aerodigestive"" cancers"
ADH1B Rs1229984 oral and laryngeal cancer
ADH1C Rs283413 PD
ADH1C Rs283413 affect alcohol metabolism
ADH1C Rs28730619 GSNOR
ADH1C Rs698 Spaniards
ADH1C Rs698 effects of alcohol are higher in individuals who break down (basically, detoxify) ethanol more slowly.
ADH1C Rs283413 Parkinson's disease (PD)
ADH1C Rs28730619 childhood asthma
ADH1C Rs283413 neurodegenerative diseases
ADH1C Rs698 variability in the rate at which alcohol is metabolized
ADH1C Rs283413 Parkinson's disease
ADH1C Rs283413 y the gs211 genoset. Note that the effects of alcohol are higher in individuals who break down (basically, detoxify) ethanol more slowly
ADH1C Rs283411 ADH
ADH1C Rs283411 polymorphism
ADH1C Rs283411 ADH single nucleotide polymorphism
ADH1C Rs1693482 effects of alcohol are higher in individuals who break down (basically, detoxify) ethanol more slowly.
ADH1C Rs1693482 were shown to affect alcohol metabolism
ADH1C Rs1693482 Irish alcoholics
ADH1C Rs283413 alcohol metabolism
ADIPOQ Rs822393 Adipokine
ADIPOQ Rs822395 Single nucleotide polymorphisms
ADIPOQ Rs822395 breast cancer
ADIPOQ Rs822395 colorectal cancer
ADIPOQ Rs822395 overweight and obesity.
ADIPOQ Rs822395 coronary heart disease
ADIPOQ Rs822395 coronary artery disease risk
ADIPOQ Rs822395 overweight
ADIPOQ Rs822395 obesity
ADIPOQ Rs182052 ischemic stroke
ADIPOQ Rs822396 incident myocardial infarction and ischemic stroke
ADIPOQ Rs822396 coronary heart disease
ADIPOQ Rs822396 breast cancer risk
ADIPOQ Rs822396 type 2 diabetes
ADIPOQ Rs182052 type 2 diabetes
ADIPOQ Rs182052 diabetes-related quantitative traits
ADIPOQ Rs182052 birth weight
ADIPOQ Rs822396 colorectal cancer
ADIPOQ Rs1501299 breast cancer
ADIPOQ Rs17300539 increased risk of insulin resistance
ADIPOQ Rs17300539 obesity
ADIPOQ Rs17300539 insulin resistance
ADIPOQ Rs17300539 weight regain
ADIPOQ Rs17300539 SNP
ADIPOQ Rs182052 polymorphisms
ADIPOQ Rs17300539 diabetes risk
ADIPOQ Rs17300539 risk of insulin resistance
ADIPOQ Rs182052 incident myocardial infarction
ADIPOQ Rs182052 ischemic stroke
ADIPOQ Rs182052 plasma adiponectin levels
ADIPOQ Rs182052 prostate cance
ADIPOQ Rs182052 insulin sensitivity
ADIPOQ Rs17300539 diabetes
ADIPOQ Rs822396 ischemic stroke
ADRB1 Rs1801253 heart failure
ADRB1 Rs1801253 women without obstructive coronary artery disease
ADRB1 Rs1801253 myocardial infarction
ADRB1 Rs1801253 heart problem
ADRB1 Rs1801253 women
ADRB1 Rs1801253 patients high blood pressure
ADRB1 Rs1801253 obstructive coronary artery disease
ADRB1 Rs1801253 high blood pressure
ADRB1 Rs1801253 coronary angiography
ADRB1 Rs1801253 lowering blood pressure
ADRB1 Rs1801252 high blood pressure
ADRB1 Rs1801252 lowering blood pressure
ADRB2 Rs1042714 obesity
ADRB2 Rs1042714 hypertension
ADRB2 Rs1042714 type-2 diabetes
ADRB2 Rs1042713 young asthma patients
ADRB2 Rs1042713 patients using inhalers less than once per day
ADRB2 Rs1042713 young Scottish asthma patients
ADRB2 Rs1042713 age, 3-22 years
ADRB2 Rs1042713 asthma
ADRB2 Rs1042713 """exacerbations"" of their condition"
ADRB3 Rs4994 subtle increases in risk for all of the individual endpoints, and was only seen in women without obstructive coronary artery disease
ADRB3 Rs4994 ndividuals were calculated to be at higher risk
ADRB3 Rs4994 experienced a heart problem
ADRB3 Rs4994 coronary angiography
AFG3L2 Rs151344523 spinocerebellar ataxia-28
AGT Rs5050 Alzheimer disease candidate genes
AGT Rs5050 haplotype clade in ACE
AGT Rs5050 Alzheimer
AGT Rs4762 diabetic retinopathy.
AGT Rs4762 Alzheimer disease
AGT Rs4762 coronary artery disease
AGT Rs4762 pre-eclampsia
AGT Rs4762 diabetic retinopathy
AGT Rs4762 heart failure
AGT Rs3889728 pre-eclampsia,
AGT Rs3889728 pre-eclampsia
AGT Rs387906578 OMIM
AGT Rs387906578 OMIM
AGT Rs121912702 OMIM
AGT Rs5051 essential hypertension
AGTR1 Rs5182 reduced risk of heart attack
AGXT Rs111996685 pathogenic
AHCY Rs6058017 appearance
AHCY Rs819134 methylations
AHCY Rs819147 regulation of biologic methylations
AHCY Rs819171 regulation of biologic methylations
AHSG Rs2248690 coronary atherosclerosis
AHSG Rs2518136 type-2 diabetes
AHSG Rs2518136 Caucasians
AHSG Rs4917 increased risk for leanness
AHSG Rs2593813 leanness
AHSG Rs2248690 directly associated
AHSG Rs2593813 Homozygosity
AHSG Rs4917 obesity
AHSG Rs4917 body fat levels
AHSG Rs4917 insulin sensitivity
AHSG Rs4917 reduced plasma lipid levels
AHSG Rs4917 lower body fat concentrations
AHSG Rs2593813 AHSG gene
AHSG Rs2248690 polymorphisms
AHSG Rs2248690 polymorphism
AHSG Rs2248690 nucleotide
AHSG Rs2077119 SNP
AHSG Rs2077119 Danish
AHSG Rs2077119 type-2
AHSG Rs2077119 diabetes
AHSG Rs2077119 light protective effect
AHSG Rs2077119 rs2077119
AHSG Rs2077119 a SNP
AHSG Rs2077119 glycoprotein AHSG gene
AHSG Rs2248690 glycoprotein
AHSG Rs2248690 type 2 diabetes
AHSG Rs2248690 French Caucasians
AHSG Rs2248690 transcriptional activity
AHSG Rs2248690 functional
AHSG Rs2077119 Danish type-2 diabetes patients
AIPL1 Rs62637014 Leber congenital amaurosis type 4
AIPL1 Rs62637014 variant
AIPL1 Rs62637014 mutation
AIPL1 Rs62637014 inherited
AIPL1 Rs62637014 recessively
AIPL1 Rs62637014 Leber congenital amaurosis
AIPL1 Rs62637014 mutation
AIPL1 Rs62637014 type 4
AKT1 Rs3730358 Korean population
AKT1 Rs3730358 lung cancer
AKT1 Rs3730358 Obstetric Complications
AKT1 Rs3730358 schizophrenia
AKT1 Rs3730358 cell lung cancer
AKT1 Rs3730358 no
AKT1 Rs3730358 associations with schizophrenia: meta-analyses of 12 candidate genes. Absence of AKT1 mutations in glioblastoma. No association betwee
AKT1 Rs3730358 non-small cell lung cancer.
AKT1 Rs3730358 polymorphism
AKT1 Rs3730358 Taiwanese population
AKT1 Rs2494732 psychotic disorde
AKT1 Rs2494732 mind-altering symptoms
AKT1 Rs2494732 once-a-month cannabis users
AKT1 Rs2494732 cannabis-related psychosis
AKT1 Rs2494732 drug-related psychoses,
AKT1 Rs2494732 , schizophrenia
AKT1 Rs3730358 glioblastoma
ALB Rs78340021 analbuminemia
ALB Rs77514449 three genetic variants of human serum albumin modified
ALB Rs77514449 Amino acid substitutions in inherited albumin variants
ALB Rs77514449 IIIA
ALB Rs77514449 IIB
ALB Rs77514449 inherited albumin
ALB Rs77514449 Japanese
ALB Rs77514449 Amerindian
ALB Rs78340021 Novel nonsense mutation
ALB Rs77514449 Amino acid substitutions in inherited albumin variants from Amerindian and Japanese populations
ALB Rs77514449 albumin variants
ALB Rs77514449 human serum albumin
ALB Rs78340021 analbuminemia
ALB Rs78784172 splicing mutation
ALB Rs79744198 Point
ALB Rs78784172 Analbuminemia
ALB Rs78784172 novel splicing mutation
ALB Rs78784172 albuminemia
ALB Rs79228041 melanoma
ALB Rs79228041 Exome sequencing identifies GRIN2A as frequently mutated in melanoma.
ALB Rs79228041 Amino acid substitution in two identical inherited human serum albumin variants: albumin Oliphant and albumin Ann Arbor
ALB Rs79744198 abnormality of albumin
ALB Rs79744198 The molecular abnormality of albumin
ALB Rs79744198 Asp----Gly.
ALB Rs79744198 natural mutants
ALB Rs77050410 Mutations in genetic variants of human serum albumin found in Italy.
ALB Rs78340021 nonsense
ALB Rs76593094 Point substitutions in Japanese alloalbumins.
ALB Rs75152012 mutation
ALB Rs76483862 Point substitutions in Japanese alloalbumins.
ALB Rs76593094 alloalbumins
ALB Rs1800580 Albumin Rugby Park
ALB Rs1800580 truncated albumin variant
ALB Rs75152012 analbuminemia
ALB Rs75152012 teroid-sensitive idiopathic nephrotic syndrome
ALB Rs75152012 acute glomerulonephritis
ALB Rs75152012 mutational analysis.
ALB Rs75152012 congenital analbuminemia and steroid-sensitive idiopathic nephrotic syndrome:
ALB Rs75152012 Congenital analbuminemia with acute glomerulonephritis:
ALB Rs75152012 Amerindian
ALB Rs75152012 Analbuminemia
ALB Rs75152012 gypsy
ALB Rs75152012 mutational
ALB Rs75152012 boy
ALB Rs75152012 congenital analbuminemia
ALB Rs75152012 steroid-sensitive idiopathic nephrotic syndrome
ALB Rs75152012 male
ALB Rs75152012 Kayseri mutation
ALB Rs75152012 Congenital analbuminemia
ALB Rs75152012 glomerulonephritis
ALB Rs76483862 alloalbumins
ALB Rs75152012 Turkish
ALDH2 Rs671 alcohol-related liver disease
ALDH2 Rs968529 effect of pesticides associated with Parkinson's disease
ALDH2 Rs968529 Aldehyde dehydrogenase variation
ALDH2 Rs968529 Aldehyde dehydrogenase
ALDH2 Rs671 in which certain individuals, often of Asian descent, have their face, neck and sometimes shoulders turn red after drinking alcoho
ALDH2 Rs671 rs671 is a classic SNP
ALDH2 Rs671 Esophageal Cancer
ALDH2 Rs671 upper aerodigestive tract (UAT) cancer
ALDH2 Rs671 esophageal cancer
ALDH2 Rs671 alcohol flush reaction
ALDH2 Rs671 alcoholism
ALDH2 Rs968529 Parkinson's disease
ALDH2 Rs671 facial flushing
ALDH2 Rs671 severe hangovers
ALDH2 Rs16941667 Parkinson's disease
ALDH2 Rs16941667 Aldehyde dehydrogenase variation
ALDH2 Rs16941667 effect of pesticides associated with Parkinson's disease
ALDH2 Rs16941667 Aldehyde dehydrogenase
ALDH2 Rs16941669 Parkinson's disease
ALDH2 Rs16941669 Aldehyde dehydrogenase variation
ALDH2 Rs16941669 effect of pesticides associated with Parkinson's disease
ALDH2 Rs671 face, neck and sometimes shoulders turn red after drinking alcohol
ALDH2 Rs16941669 Aldehyde dehydrogenase
ALDH3A2 Rs1800870 oral cancer
ALDH3A2 Rs1800870 interleukin-10 gene
ALDH3A2 Rs72547571 Sjogren-Larsson syndrome
ALDH5A1 Rs3765310 SSADH deficiency
ALDH5A1 Rs2760118 Reduc
ALDH5A1 Rs3765310 succinate semialdehyde dehydrogenase
ALDH5A1 Rs2760118 ccin
ALDH5A1 Rs2760118 United
ALDH5A1 Rs2760118 he suc
ALDH5A1 Rs2760118 dyslexia
ALDH5A1 Rs2760118 e a
ALDH5A1 Rs2760118 tive
ALDH5A1 Rs2760118 King
ALDH5A1 Rs2760118 with S
ALDH5A1 Rs2760118 accumulation
ALDH5A1 Rs2760118 mutatio
ALDH7A1 Rs864622557 Val
ALDH7A1 Rs864622557 Gly
ALDH7A1 Rs121912708 328C
ALDH7A1 Rs121912707 pyridoxine-dependent epilepsy
ALDOB Rs1800546 European ancestry
ALDOB Rs1800546 HFI
ALDOB Rs1800546 autosomal recessive
ALDOB Rs1800546 phosphate sink
ALDOB Rs1800546 halt of gluconeogenesis and glycogenolysis
ALDOB Rs1800546 bloating, abdominal pain, diarrhea, hypoglycemia, hyperuricemia, mental depression, jaundice, and cirrhosis
ALDOB Rs1800546 liver failure and death
ALDOB Rs1800546 food aversion to fructose-rich foods
ALDOB Rs1800546 avoidance of fructose-containing foods
ALDOB Rs1800546 severe hypoglycemia
ALDOB Rs1800546 altered consciousness, diaphoresis, and seizures
ALDOB Rs1800546 death
ALDOB Rs1800546 Italian patients
ALDOB Rs1800546 American
ALDOB Rs1800546 Italians
ALDOB Rs1800546 Chronic Diarrhea
ALDOB Rs1800546 hereditary fructose intolerance
ALDOB Rs76917243 ALDOB gene mutation
ALDOB I5008215 Hereditary Fructose Intolerance
ALDOB Rs1800546 fructose intolerance
ALDOB I5012663 hereditary fructosuria
ALDOB I5012664 Hereditary Fructose Intolerance
ALDOB I5012665 Hereditary fructose intolerancers
ALDOB I5012665 Hereditary fructose intolerance
ALDOB I5012665 Hereditary
ALDOB Rs1800546 =CLINICAL OVERVIEW:=
ALDOB Rs1800546 hereditary fructosuria
ALDOB Rs1800546 bloating, abdominal pain, diarrhea, hypoglycemia, hyperuricemia, mental depression, jaundice, and cirrhosis that can lead to liver failure and death.
ALDOB I5012665 fructose intolerance
ALDOB Rs1800546 altered consciousness
ALDOB Rs1800546 diaphoresis
ALDOB Rs1800546 hypoglycemia
ALDOB Rs1800546 cirrhosis
ALDOB Rs1800546 altered consciousness, diaphoresis, and seizures, sometimes resulting in death.
ALDOB Rs1800546 mental depression
ALDOB Rs1800546 inability of the body to break down fructose into byproducts for human consumption
ALDOB Rs1800546 loss of function of aldolase B
ALDOB Rs1800546 seizures
ALDOB Rs1800546 bloating, abdominal pain, diarrhea, hypoglycemia, hyperuricemia, mental depression, jaundice, and cirrhosis that can lead to liver failure and death
ALOX5AP Rs4769874 myocardial infarction
ALOX5AP Rs4769874 myocardial infarction or ischemic stroke
ALOX5AP Rs4769874 ischemic stroke
ALOX5AP Rs4769874 haplotype
ALOX5AP Rs4076128 women
ALOX5AP Rs4076128 higher breast cancer risk
ALOX5AP Rs4076128 east cancer
ALOX5AP Rs9551963 5-Lipoxygenase activating protein (ALOX5AP) gene variants associate with the presence of xanthomas in familial hypercholesterolemia.
ALOX5AP Rs4076128 breast cancer
ALOX5AP Rs9315050 myocardial infarction
ALOX5AP Rs9551963 ALOX5AP and LTA4H polymorphisms modify augmentation of bronchodilator responsiveness by leukotriene modifiers in Latinos.
ALOX5AP Rs9315050 ischemic stroke
ALOX5AP Rs9551963 myocardial infarction
ALOX5AP Rs9551963 ischemic stroke
ALOX5AP Rs9551963 atherosclerosis
ALOX5AP Rs9551963 hypercholesterolemia
ALOX5AP Rs9551963 atherothrombotic cardiovascular disease
ALOX5AP Rs9551963 rs9551963, also known as SG13S32, is an ALOX5AP gene SNP that has been defined as part of a haplotype potentially associated with risk for myocardial infarction or ischemic stroke.
ALOX5AP Rs9551963 Genetic effects in the leukotriene biosynthesis pathway and association with atherosclerosis.
ALOX5AP Rs9551963 role of LTA4H and ALOX5AP genes in the risk for asthma in Latinos.
ALOX5AP Rs4076128 ethnicity
ALOX5AP Rs17222814 ischemic stroke
ALOX5AP Rs17222842 ischemic stroke
ALOX5AP Rs17222842 haplotype potentially associated with risk for myocardial infarction or ischemic stroke
ALOX5AP Rs10507391 myocardial infarction
ALOX5AP Rs10507391 ischemic stroke
ALOX5AP Rs10507391 cardiovascular disease
ALOX5AP Rs10507391 atherosclerosis
ALOX5AP Rs10507391 diabetes
ALOX5AP Rs10507391 augmentation of bronchodilator responsiveness
ALOX5AP Rs17222842 risk for myocardial infarction
ALOX5AP Rs17222814 myocardial infarction
ALOX5AP Rs17222814 alcohol consumption
ALOX5AP Rs17222814 myocardial infarction or ischemic stroke
ALOX5AP Rs17222814 bifurcation intima-media thickness
ALOX5AP Rs10507391 leukotriene biosynthesis pathway and association with atherosclerosis
ALOX5AP Rs10507391 significant (only) in males
ALOX5AP Rs10507391 Genetic effects in the
ALPL I6006940 mutations database
ALPL I6006946 hypophosphatasia.
ALPL I6006940 odonto. form of hypophosphatasia
ALPL I6006946 rare/minor allele
ALPL I6006946 hypophosphatasia
ALPL I6006956 hypophosphatasia
ALPL I6006951 perinatal form of hypophosphatasia
ALPL I6006951 pathogenic for the perinatal form of hypophosphatasia.
ALPL I6006953 hypophosphatasia
ALPL I6006956 infantile form
ALPL I6006940 ALPL gene on chromosome
ALPL I6006948 hypophosphatasia
ALPL I6006940 pathogenic
ALPL I6006927 p.R391C
ALPL I6006940 hypophosphatasia
ALPL I6006933 hypophosphatasia
ALPL I6006927 hypophosphatasia
ALPL I6006927 pathogenic
ALPL I6006927 rare/minor allele
ALPL I6006927 ALPL gene mutations database
ALPL I6006927 ALPL gene on chromosome 1
ALPL I6006927 SNP
ALPL I6006956 pathogenic
ALPL I6006927 c.1171C>T
ALPL I6006927 i6006927
ALPL I6006940 rare/minor allele
ALPL I6006956 pathogenic for the infantile form of hypophosphatasia.
ALPL I6006996 hypophosphatasia.
ALPL I6006969 rare/minor allele
ALPL I6007032 allele
ALPL I6007032 minor
ALPL I6007032 mutations
ALPL I6007032 gene
ALPL I6007032 chromosome
ALPL I6007032 hypophosphatasia
ALPL I6007032 considered pathogenic
ALPL I6007032 rare/minor allele
ALPL I6007032 i6007032
ALPL I6007032 erinatal form of hypophosphatasia
ALPL I6007029 the rare/minor allele is considered pathogenic
ALPL I6007029 hypophosphatasia
ALPL I6007029 is a SNP in the ALPL gene on chromosome 1
ALPL I6007029 infantile form of hypophosphatasia
ALPL I6006927 pathogenic for the childhood form of hypophosphatasia
ALPL I6006996 hypophosphatasia
ALPL I6006991 P292T
ALPL I6006991 874C
ALPL I6006991 i6006991
ALPL I6006991 hypophosphatasia
ALPL I6006989 hypophosphatasia
ALPL I6006989 pathogenic
ALPL I6006969 considered pathogenic for the perinatal form of hypophosphatasia.
ALPL I6006969 perinatal form of hypophosphatasia
ALPL I6006927 gene on chromosome 1
ALPL I6006921 hypophosphatasia
ALPL I6006927 gene mutations
ALPL I5012683 hypophosphatasia
ALPL I5002774 infantile form of hypophosphatasia
ALPL I5002773 hypophosphatasia
ALPL I5002772 pathogenic for the perinatal form of hypophosphatasia
ALPL I5002772 hypophosphatasia
ALPL I5002771 hypophosphatasia
ALPL I5002766 hypophosphatasia
ALPL I5002766 perinatal form
ALPL I5002766 allele
ALPL I5002766 mutations
ALPL I5002766 ALPL gene
ALPL I5002766 chromosome
ALPL I5012683 i5012683, also known as c.1133A>T or p.D378V, is a SNP in the ALPL gene on chromosome 1.Based on the ALPL gene mutations database, the rare/minor allele is considered pathogenic for the infan
ALPL I5002766 perinatal form of hypophosphatasia
ALPL I5002766 is a SNP in the ALPL gene on chromosome
ALPL I5002766 is considered pathogenic for
ALPL I5002765 hypophosphatasia
ALPL I5002757 hypophosphatasia
ALPL I5002756 perinatal form of hypophosphatasia
ALPL I5002756 pathogenic
ALPL I5002756 ypophosphatasia
ALPL I6007032 pathogenic
ALPL I5002766 SNP
ALPL I5012683 infantile form of hypophosphatasia
ALPL I5012684 .Based on the ALPL gene mutations
ALPL I6006927 childhood form of hypophosphatasia
ALPL I6006927 childhood form of hypophosphatasia.
ALPL I6006926 hypophosphatasia
ALPL I6006921 ALPL gene
ALPL I6006921 the rare/minor allele
ALPL I6006921 ALPL gene
ALPL I6006921 chromosome 1
ALPL I6006921 SNP
ALPL I6006921 childhood
ALPL I6006912 adult form of hypophosphatasia
ALPL I6006912 i6006912, also known as c.512A>G or p.H171R, is a SNP in the ALPL gene on chromosome 1.Based on the ALPL gene mutations database, the rare/minor allele is considered pathogenic for the adult form of hypophosphatasia
ALPL I6006912 i6006912, also known as c.512A>G or p.H171R, is a SNP in the ALPL gene on chromosome 1.Based on the ALPL gene mutations database, the rare/minor allele is considered pathogenic for the adult form of hypophosphatasia.
ALPL I6006912 6006912, also known as c.512A>G or p.H171R, is a SNP in the ALPL gene on chromosome 1.Based on the ALPL gene mutations database, the rare/minor allele is considered pathogenic for the adult form of hypophosphatasia.
ALPL I6006912 i6006912, also known as c.512A>G or p.H171R, is a SNP in the ALPL gene on chromosome 1.Based on the ALPL gene mutations database, the rare/minor allele is considered pathogenic for the
ALPL I6006912 hypophosphatasia
ALPL I6006897 hypophosphatasia.
ALPL I6006897 rare/minor allele
ALPL I6006897 hypophosphatasia
ALPL I6006889 hypophosphatasia
ALPL I6006889 pathogenic
ALPL I6006889 gene mutations
ALPL I6006889 chromosome
ALPL I6006889 p.T134N
ALPL I6006888 hypophosphatasia
ALPL I5900451 hypophosphatasia.
ALPL I6006927 considered pathogenic for the childhood form of hypophosphatasia.
AMPD1 Rs35859650 muscle AMP deaminase deficiency
AMPD1 Rs35859650 recessively inherited mutation
ANG Rs11701 ALS
ANG Rs11701 amyotrophic lateral sclerosis
ANG Rs17114699 amyotrophic lateral sclerosis
ANG Rs17114699 Irish
ANG Rs17114699 Swedish
ANG Rs17114699 Polish
ANG Rs17114699 amyotrophic lateral sclerosis (ALS) in Irish and Swedish populations, but not in Polish populations
ANGPTL3 Rs398122987 ANGPTL3
ANGPTL3 Rs267606655 lowered triglycerides and LDL cholesterol
ANGPTL3 Rs267606655 function variant in the ANGPTL3 gene on chromosome
ANGPTL3 Rs267606655 coronary artery disease.
ANGPTL3 Rs267606655 coronary artery disease
ANGPTL3 Rs267606655 minor allele
ANGPTL3 Rs267606655 artery disease
ANGPTL3 Rs267606655 coron
ANK2 Rs72544141 Ankyrin-B mutation causes type 4 long-QT cardiac arrhythmia and sudden cardiac death. A cardiac arrhythmia syndrome caused by loss of ankyrin-B function. Dysfunction in ankyrin-B-dependent ion channel and transporter targeting causes human sinus node disease.
ANK2 Rs72544141 Ankyrin-B mutation
ANK2 Rs72544141 causes type 4 long-QT
ANK2 Rs72544141 cardiac arrhythmia
ANK2 Rs72544141 sudden cardiac death